Free Trial

AptarGroup Q3 2023 Earnings Report

AptarGroup logo
$158.18 -0.69 (-0.43%)
(As of 12/20/2024 05:31 PM ET)

AptarGroup EPS Results

Actual EPS
$1.39
Consensus EPS
$1.28
Beat/Miss
Beat by +$0.11
One Year Ago EPS
N/A

AptarGroup Revenue Results

Actual Revenue
$893.00 million
Expected Revenue
$889.92 million
Beat/Miss
Beat by +$3.08 million
YoY Revenue Growth
N/A

AptarGroup Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

Conference Call Audio

Slide Deck

Trump’s Sending THIS Crypto Higher on Purpose (Ad)

Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…

YES, I WANT THE #1 CRYPTO NOW

AptarGroup Earnings Headlines

AptarGroup Has Gotten Too Expensive
Why I'm telling friends to avoid gold stocks
Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."
Is Now The Time To Put AptarGroup (NYSE:ATR) On Your Watchlist?
AptarGroup, Inc. (ATR)
See More AptarGroup Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like AptarGroup? Sign up for Earnings360's daily newsletter to receive timely earnings updates on AptarGroup and other key companies, straight to your email.

About AptarGroup

AptarGroup (NYSE:ATR) designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions. In addition, the company offers dispensing pumps, closures, elastomeric components, and aerosol valves to the digital health solutions. It primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.

View AptarGroup Profile

More Earnings Resources from MarketBeat

Upcoming Earnings